| Name | 5-({6-[(4'-Carboxy-2,3'-bithiophen-5'-yl)amino]-6-oxohexanoyl}amino)-2,3'-bithiophene-4'-carboxylic acid |
|---|---|
| Synonyms |
5-({6-[(4'-Carboxy-2,3'-bithiophen-5'-yl)amino]-6-oxohexanoyl}amino)-2,3'-bithiophene-4'-carboxylic acid
[2,3'-Bithiophene]-4'-carboxylic acid, 5-[[6-[(4'-carboxy[2,3'-bithiophen]-5'-yl)amino]-1,6-dioxohexyl]amino]- |
| Description | TM5007 is a poent and orally active inhibitor of plasminogen activator inhibitor-1 (PAI-1) with an IC50 of 29 μM. TM5007 enhance fibrinolysis activity and inhibits coagulation. TM5007 also prevents the fibrotic process initiated by bleomycin in mouse lung[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 800.4±65.0 °C at 760 mmHg |
| Molecular Formula | C24H20N2O6S4 |
| Molecular Weight | 560.69 |
| Flash Point | 437.8±34.3 °C |
| Exact Mass | 560.020386 |
| LogP | 4.96 |
| Vapour Pressure | 0.0±3.0 mmHg at 25°C |
| Index of Refraction | 1.730 |